Ignite Creation Date:
2025-12-25 @ 2:24 AM
Ignite Modification Date:
2026-01-24 @ 5:33 PM
Study NCT ID:
NCT03935334
Status:
COMPLETED
Last Update Posted:
2021-02-04
First Post:
2019-04-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With Inhibitors
Sponsor:
AryoGen Pharmed Co.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
UGA 2014-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None